GPBMC infusion

BIOLOGICAL2 trials

Sponsors

Beijing 302 Hospital

Conditions

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Phase 2

Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML

RecruitingNCT07078591

Beijing 302 HospitalAcute Myeloid Leukemia

Start: 2025-06-20End: 2031-06-30Target: 50Updated: 2025-07-28

Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS

RecruitingNCT07238686

Beijing 302 HospitalMyelodysplastic Syndromes

Start: 2025-06-20End: 2031-06-30Target: 40Updated: 2025-11-25